OOIR: Observatory of International Research

Papers

(The H4-Index of Current Neuropharmacology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Mimicking Extracellular Matrix via Engineered Nanostructured Biomaterials for Neural Repair	136
Role of Glycerophospholipid Metabolism in Epilepsy	114
Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction	113
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study	98
Childhood Trauma and Self-harm in Youths with Bipolar Disorders	97
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management	81
Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson’s Disease: An Update Since 2017	80
Local and Remote Chemogenetic Suppression of Hippocampal Seizures in Rats	78
Redox Modulation of Meniere Disease by Coriolus versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective Potential	77
Early Family Intervention for Youth at Risk for Bipolar Disorder: Psychosocial and Neural Mediators of Outcome	71
Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS	70
The Effects of Drugs used for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Pregnancy Outcome and Breast-feeding: A Critical Review	69
Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease	61
Modulating Ferroptosis: A Novel Approach to Promote Neural Repair in Brain Injury	60
The Role of Natural Products in Treatment of Depressive Disorder	59
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder	57
Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring	56
siRNA Therapeutics: Future Promise for Neurodegenerative Diseases	49
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study	46
Thematic Selection: Stress and Stress-related Disorders Neurobiology & Translational Aspects of Stress-related Disorders (Part 3)	46
Meet the Editorial Board Member	46
Exploring Mechanistic Insights by Carotenoids in Neuropathic and Inflammatory Pain	45
Antiseizure Medications: Advancements, Challenges, and Prospects in Drug Development	45
The Mechanisms and Application Prospects of Astrocyte Reprogramming into Neurons in Central Nervous System Diseases	43
The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation	42

Myeloid-derived Suppressor Cells and Multiple Sclerosis	41
Unveiling the Potential Neuroprotective Effect of Bioactive Compounds from Plants with Sedative and Mood-Modulating Properties: Innovative Approaches for the Prevention of Alzheimer's and Parkinson's	39
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy	39
Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis	38
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics	38
What is the Role of Lithium in Epilepsy?	37
Perspective on the Relationship between GABAA Receptor Activity and the Apparent Potency of an Inhibitor	37
Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials	36
Antioxidants, Hormetic Nutrition, and Autism	35
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment	34
Effects of Deep Brain Stimulation on Sleep-Wake Disturbances in Patients with Parkinson's Disease: A Narrative Review	34